Mycobacterial Lineages Causing Pulmonary and Extrapulmonary Tuberculosis, Ethiopia by Firdessa, R et al.
DISPATCHES
460	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	19,	No.	3,	March	2013
Mycobacterial 
Lineages Causing 
Pulmonary and 
Extrapulmonary 
Tuberculosis, 
Ethiopia
Rebuma Firdessa,1,2 Stefan Berg,1 Elena Hailu,1 
Esther Schelling, Balako Gumi, Girume Erenso, 
Endalamaw Gadisa, Teklu Kiros,  
Meseret Habtamu, Jemal Hussein,  
Jakob Zinsstag, Brian D. Robertson,  
Gobena Ameni, Amanda J. Lohan,  
Brendan Loftus, Iñaki Comas,  
Sebastien Gagneux, Rea Tschopp,  
Lawrence Yamuah, Glyn Hewinson,  
Stephen V. Gordon, Douglas B. Young,  
and Abraham Aseffa
Molecular typing of 964 specimens from patients in 
Ethiopia with lymph node or pulmonary tuberculosis showed 
a similar distribution of Mycobacterium tuberculosis strains 
between the 2 disease manifestations and a minimal role 
for M. bovis. We report a novel phylogenetic lineage of M. 
tuberculosis strongly associated with the Horn of Africa.
Ethiopia is among the countries with the highest incidence of tuberculosis (TB) and has a yearly incidence of 261 
cases/100,000 population. TB lymphadenitis in cervical 
lymph nodes (TBLN) accounts for ≈33% of all new cases 
in this country, which is greater than the global average of 
≈15% (1). Ethiopia has the largest livestock population in 
Africa (≈51 million cattle), and recent studies have shown 
that bovine TB is endemic in this country (estimated preva-
lence 1%–10%) (2).
To explore the public health risk for bovine TB in Ethi-
opia, we have used molecular typing to characterize myco-
bacterial isolates from persons with TBLN and pulmonary 
TB who were visiting hospitals throughout the country. 
Our aim was to define the role of Mycobacterium bovis in 
human TB and to define the overall structure of the M. tu-
berculosis complex in Ethiopia.
The Study
Patients with suspected TBLN or pulmonary TB who 
came to hospitals or health centers in study sites and pro-
vided voluntary consent were recruited into the study dur-
ing 2006–2010. Fine needle–aspirate samples and sputum 
samples were collected from 2,151 patients attending hos-
pitals in Gondar, Woldiya, Ghimbi, Butajira, and Negelle, 
Ethiopia. In addition, sputum samples were collected from 
patients at hospitals in Fiche, Jinka, and Filtu and at health 
centers at 3 suburban sites in Addis Ababa (Holeta, Sululta, 
and Chancho). Samples were cultured on Löwenstein-Jen-
sen medium supplemented with glycerol or pyruvate and 
on modified Middlebrook 7H11 medium optimized for cul-
ture of M. bovis.
We characterized isolates belonging to the M. tu-
berculosis complex by using multiplex PCR for large 
sequence polymorphisms (3,4), spoligotyping (5), and 
lineage-specific single-nucleotide polymorphism analysis 
(4,6). Isolates of selected spoligotypes were characterized 
by 24-loci mycobacterial interspersed repetitive unit–vari-
able number tandem repeat (MIRU-VNTR) analysis (7). 
Four M. tuberculosis isolates from a group of 36 with un-
usual spoligotype patterns were further characterized by 
genome sequencing (Illumina Inc., San Diego, CA, USA). 
Sequencing reads were mapped to the inferred most re-
cent common ancestor of the M. tuberculosis complex (6). 
A final alignment of 13,199 single-nucleotide polymor-
phism positions was generated and analyzed by using the 
neighbor-joining method with a Tamura-Nei evolutionary 
model (www.megasoftware.net/mega_papers.php). Non-
tuberculous mycobacteria were characterized by sequenc-
ing of the 16S rDNA gene.
Characteristics of 964 cultures positive for acid-fast 
bacilli are summarized in Table 1. Most of these isolates 
had an intact RD9 region, which identified them as M. 
tuberculosis. Only 4 (0.4%) of 964 isolates had undergone 
RD9 and RD4 deletions characteristic of M. bovis (3). The 
4 M. bovis isolates were obtained from cases of pulmonary 
TB, 3 of which were from patients living in pastoralist 
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communities in southern Ethiopia. The 10 nontuberculous 
mycobacterial isolates were identified as M. intracellulare, 
M. flavescens, and M. simiae; 2 of the isolates were from 
patients co-infected with M. tuberculosis.
Among the 954 isolates belonging to the M. tuberculo-
sis complex, 671 (71%) belonged to lineage 4, which was 
the most common lineage in Ethiopia. However, lineage 
3 was most prevalent in the northern sites of Gondar and 
Woldiya (122/257, 47%). Eleven strains belonging to lin-
eage 1 were isolated in the southern region. Two isolates 
with a characteristic Beijing family spoligotype (spoligo-
type international type [SIT] 1) were identified as pseudo-
Beijing strains belonging to lineage 3 (8). Thirty-six iso-
lates with an unusual spoligotype pattern (missing spacers 
4–24) and intact for the TbD1 region could not be assigned 
to known lineages. Genome sequencing identified these 
strains as members of a new lineage (lineage 7) localized 
between ancient lineage 1 and modern lineages 2, 3, and 4 
of M. tuberculosis phylogeny (Figure 1). This new lineage 
7 was prominent among strains collected in the Woldiya 
region (17/133 strains, 13%) (Table 1).
Lineage distribution was identical between the 2 dis-
ease forms at the national level; lineage 4 was isolated from 
71% (442/662) and 70% (229/328) of pulmonary TB and 
TBLN patients, respectively, and lineage 3 was isolated 
from 25% (153/622) and 24% (79/328), respectively. The 
M. tuberculosis isolates encompassed 176 spoligotypes 
(online Technical Appendix Table 1, wwwnc.cdc.gov/EID/
article/19/3/12-0256-Techapp1.xls), of which 86 patterns 
were new to the international genotyping database 2 (SIT-
VIT2) (www.pasteur-guadeloupe.fr:8081/SITVITDemo/) 
(9). A total of 11% (101/950) of the isolates represented 
single spoligotypes, and 62% (591/950) were included in 
10 major spoligotype clusters (Table 2).
There was no difference in cluster distribution between 
pulmonary TB and lymph node TB isolates; 10% and 
Table 1. Mycobacterium spp. and strains, Ethiopia, 2006–2010* 
Collection site 
Pulmonary TB 
M. 
bovis 
 
NTM 
 TBLN 
M. bovis 
 
NTM 
M. tuberculosis†  M. tuberculosis† 
Total L4 L3 L7 L1  Total L4 L3 L7 L1 
Gondar 92 32 58 2 0 0 0  32 21 11 0 0 0 0 
Woldiya 23 9 10 4 0 0 0  110 54 43 13 0 0 5 
Ghimbi 47 40 6 1 0 0 0  69 58 11 0 0 0 0 
Fiche‡ 169 128 35 6 0 1 0  NA NA NA NA NA NA NA 
Addis Ababa‡ 60 50 7 3 0 0 0  NA NA NA NA NA NA NA 
Butajira 70 60 9 1 0 0 0  110 91 13 6 0 0 0 
Negelle/Filtu/Jinka 161 123 28 0 10 3 3  7 5 1 0 1 0 2 
Total isolates 622 442 153 17 10 4 3  328 229 79 19 1 0 7 
Total M. tuberculosis % 100 71.1 24.6 2.7 1.6 NA NA  100 69.8 24.1 5.8 0.3 NA NA 
*Values	are	no.	isolates.	TB,	tuberculosis;	TBLN,	TB	lymphadenitis	in	cervical	lymph	nodes;	NTM,	nontuberculous	mycobacteria;	NA,	not	applicable. 
†Lineage	of	M. tuberculosis is	expressed	by	an	L	followed	by	a	digit. 
‡TBLN	samples	were	not	collected	in	Fiche	and	Addis	Ababa. 
 
Figure	 1.	 Lineages	 of	 the	 Mycobacterium 
tuberculosis	 (MTB)	 complex,	 Ethiopia,	 2006–
2010. Genome sequence analysis of 4 strains 
representative	of	36	related	 isolates	 identified	
them as members of a new phylogenetic 
lineage (lineage 7) of M. tuberculosis, which has 
a phylogenetic location intermediate between 
ancient	 lineage	1	and	modern	Lineages	2,	3,	
and 4, and a branch point before the deletion 
of the TbD1 region (3).	 Nomenclatures	 for	
lineage names and numbers are as proposed 
(4,6).	Phylogeny	shown	is	based	on	13,199	nt	
positions that were variable in at least 1 of the 
28 M. tuberculosis	complex	strains	represented	
in	 the	 tree.	 Numbers	 near	 nodes	 indicate	
percentage of bootstrap replicates supporting 
the topology after 1,000 pseudoreplicates. 
MAF, M. africanum;	MBO,	M. bovis.
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11%, respectively, were single types, and 64% and 60%, 
respectively, were included in dominant clusters. Two large 
clusters representative of lineage 4 (SIT 149) and lineage 
3 (SIT 25) were further characterized by MIRU-VNTR 
typing (online Technical Appendix Table 2) and network 
analysis (Figure 2). In each case, TBLN and pulmonary TB 
samples were dispersed throughout the network of spoligo-
type clusters.
All 4 M. bovis isolates from humans showed typical 
bovine spoligotype profiles lacking spacers 3, 9, 16, and 
39–43. In addition, they lacked spacers 4–7 and had dele-
tions of RDAf2, which are features that define strains of 
the African 2 clonal complex of M. bovis reported from 
TB-infected cattle in Ethiopia (10).
Conclusions
The frequency of M. bovis in persons in this study 
(0.4%) is similar to that found in other studies of human TB 
in Africa (11) and South and Central America (12), but much 
lower than that observed among selected populations in Tan-
zania (16%) (13), Ethiopia (17%) (14), and Mexico (28%) 
(15). These findings indicate that the overall contribution of 
M. bovis to human TB is minor but greater in specific areas. 
In Ethiopia, monitoring of zoonotic transmission is needed 
in urban areas with high rates of bovine TB associated with 
intensive farming of imported dairy cattle (R. Firdessa et al., 
unpub. data) and among pastoralist populations from which 
human M. bovis cases were identified in this study.
Zoonotic transmission of M. bovis can be excluded 
as the predominant cause of the high national incidence of 
TBLN in Ethiopia. Mapping of disease networks by spoligo-
typing and MIRU-VNTR analysis showed an integrated dis-
tribution of the 2 disease forms, which suggested that cases 
of TBLN arise from within the pulmonary TB transmission 
network, rather than from an external zoonotic source.
We identified a novel phylogenetic lineage of M. 
tuberculosis (lineage 7) in multiple sites and at a high 
frequency in Woldiya in the northeastern highlands of 
Ethiopia. Screening of the SITVIT2 database (9) and the 
US Centers for Disease Control and Prevention National 
Tuberculosis Genotyping Surveillance Network Data-
base (L.S. Cowan, pers. comm.) identified 23 (0.03%) of 
»90,000 isolates as members of lineage 7; all were iso-
lated from patients whose country of origin (when known) 
was in the Horn of Africa. Lineage 7 is of considerable 
evolutionary interest because it represents a phylogenetic 
branch intermediate between the ancient and modern lin-
eages of M. tuberculosis (3,4,6).
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Table 2. Major spoligotype clusters of Mycobacterium tuberculosis, Ethiopia, 2006–2010* 
SIT no. SITVIT2 Lineage 
No.	isolates	from	each	site Disease 
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37 T3 4 2 2 23 8 7 9 10 39 22 
3134 New 4 1 1 3 4 2 33 0 26 18 
26 CAS1 3 7 3 2 8 4 4 4 25 7 
21 CAS1 3 5 2 1 3 0 0 7 16 2 
41 LAM7-TUR 4 3 0 3 5 0 0 6 12 5 
1729 Undesignated 7 0 13 0 3 0 1 0 5 12 
4 LAM3 4 1 3 0 2 0 1 9 11 5 
910 Undesignated 7 1 3 1 2 3 4 0 10 4 
*SIT, spoligotype international	type;	SITVIT2,	SIT	international genotyping database 2;	Go,	Gondar;	Wo,	Woldiya;	Gi,	Ghimbi;	Fi,	Fiche;	AA,	Addis	Ababa;	
Bu,	Butajira;	NFJ,	Negelle,	Filtu,	and	Jinka;	PTB,	pulmonary	TB;	TBLN,	TB	lymphadenitis	in	cervical	lymph	nodes. 
 
Figure 2. Mycobacterial interspersed repetitive unit–variable number 
tandem	repeat	(MIRU-VNTR)	networks	of	major	spoligotype	clusters,	
Ethiopia, 2006–2010. Two large sopligotype clusters from lineage 4 
(A)	(90	isolates	of	sopligotype	149)	and	lineage	3	(B)	(73	isolates	
of	 spoligotype	 25)	 were	 further	 characterized	 by	 24-loci	 MIRU-
VNTR	typing	(online	Technical	Appendix	Table	2,	wwwnc.cdc.gov/
EID/article/19/3/12-0256-Techapp1.xls).	 Minimum-spanning	 trees	
were	calculated	 for	each	cluster	by	using	MIRU-VNTRplus (www.
miru-vntrplus.org). Each circle indicates an individual genotype. 
Genotypes	L	and	E1	include	>15	isolates	and	remaining	genotypes	
include	 <15	 isolates.	Genotypes	 indicated	 by	 a	 black	 circle	were	
isolated	from	patients	with	pulmonary	tuberculosis	(TB);	those	in	light	
gray were isolated from patients with TB lymphadenitis in cervical 
lymph	nodes	(TBLN);	and	those	in	dashed	circles	were	isolated	from	
patients	with	pulmonary	TB	and	those	with	TBLN.	Numbers	on	lines	
between circles indicate distance between 2 genotypes.
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